IMV



dynaCERT Inc.
Latest Comments
image_pdfimage_print

Drolet Stock Notes on IMV Inc.: A clinical stage company developing a first-in-class T cell targeted immune therapy for cancer

Mario Drolet, President of MI3 Communications Financières Inc. (MI3), released his Drolet Stock Notes on IMV Inc. (NASDAQ: IMV | […]


MI3 Market Alert: Transforming the way, we harness Human Immunity

Mario Drolet President of MI3 Communications Financières Inc. (MI3) released a technical note at market open today on IMV Inc. […]